0 CHECKOUT

Algeria Pharmaceuticals and Healthcare Report Q2 2016

  • ID: 3621227
  • February 2016
  • Region: Algeria
  • 89 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Groupe Saidal
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

Despite a slowdown in the Algerian economy due to low oil prices, the country's pharmaceutical and healthcare markets are expected to sustain their positive growth trajectory over a multi-quarter horizon. The health sector expansion will be supported by long-term drivers such as growing demand for healthcare and treatment, healthcare system modernisation and sustained foreign investment in domestic drug manufacturing. Although we expect foreign investors to continue benefitting from government incentives aimed at boosting domestic pharmaceutical production and technology transfer, operating challenges will continue weigh on the market's full potential.

Headline Expenditure Projections

- Pharmaceuticals: DZD411.62bn (USD4.12bn) in 2015 to DZD451.90bn (USD4.13bn) in 2016; +9.8% in local currency and +0.3% in US dollar terms. Forecast in line with last quarter.

- Healthcare: DZD1,113.59bn (USD11.13bn) in 2015 to DZD1,204.64bn (USD11.00bn) in 2016; +8.2% in local currency and -1.2% in US dollar terms. Forecast revised upwards in local currency terms and downwards in US dollar terms from last quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • GlaxoSmithKline
  • Groupe Saidal
  • Merck & Co
  • Novartis
  • Pfizer
  • Sanofi
  • MORE

- Industry View

- Table: Headline Pharmaceuticals & Healthcare Forecasts (Algeria 2014-2020)

- SWOT

- Industry Forecast

- Pharmaceutical Market Forecast

- Table: Pharmaceutical Sales, Historical Data And Forecasts (Algeria 2012-2020)

- Healthcare Market Forecast

- Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020)

- Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020)

- Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020)

- Prescription Drug Market Forecast

- Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)

- Patented Drug Market Forecast

- Table: Patented Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)

- Generic Drug Market Forecast

- Table: Generic Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)

- OTC Medicine Market Forecast

- Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)

- Pharmaceutical Trade Forecast

- Table: Pharmaceutical Trade Data And Forecasts (Algeria 2014-2020)

- Table: Pharmaceutical Trade Data And Forecasts local currency (Algeria 2014-2020)

- Industry Risk/Reward Index

- Middle East and Africa Risk/Reward Index - Q2 2016

- Algeria Risk/Reward Index

- Rewards

- Risks

- Regulatory Review

- Intellectual Property Issues

- Pricing Regime

- Reimbursement Regime

- Market Overview

- Healthcare Sector

- Research & Development

- Clinical Trials

- Epidemiology

- Competitive Landscape

- Research-Based Industry

- Table: Multinational Market Activity

- Generic Drugmakers

- Pharmaceutical Distribution

- Pharmaceutical Retail

- Company Profile

- GlaxoSmithKline

- Groupe Saidal

- Merck & Co

- Novartis

- Pfizer

- Sanofi

- Demographic Forecast

- Demographic Outlook

- Table: Population Headline Indicators (Algeria 1990-2025)

- Table: Key Population Ratios (Algeria 1990-2025)

- Table: Urban/Rural Population & Life Expectancy (Algeria 1990-2025)

- Table: Population By Age Group (Algeria 1990-2025)

- Table: Population By Age Group % (Algeria 1990-2025)

- Glossary

- Methodology

- Pharmaceutical Expenditure Forecast Model

- Healthcare Expenditure Forecast Model

- Notes On Methodology

- Risk/Reward Index Methodology

- Index Overview

- Table: Pharmaceutical Risk/Reward Index Indicators

- Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

- GlaxoSmithKline
- Groupe Saidal
- Merck & Co
- Novartis
- Pfizer
- Sanofi

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S